Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

The Most Concerning Thing About Pfizer's Dividend Isn't What You Think

Pfizer's payout ratio is above 100%, but that's not the number you should probably be watching right now.

The Most Concerning Thing About Pfizer's Dividend Isn't What You Think

Published August 27, 2026 · Category: Finance

Overview

Pfizer (NYSE: PFE) has an attractive 6.1% dividend yield, as of this writing. That compares with roughly a 1% yield for the S&P 500 index (SNPINDEX: ^GSPC) and a 1.4% yield for the average pharmaceutical stock. Investors should probably be worried about Pfizer's shockingly high yield. But you may not be looking at the right metric to gauge how worried you should be.

Most investors look at the dividend payout ratio when they consider dividend safety. This metric compares dividends to earnings, which is a logical concept. If a company earns more than it pays in dividends, the dividend should be safe. Pfizer's dividend payout ratio is currently above 200%, which is not comforting.

Image source: Getty Images.

Details

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.